|
|
home > white papers > Is Your Biobank Ready for the Challenge of Biomarker-based Research? - BioFortis |
 |
 |
WHITE PAPERS |
|
BioFortis
|
Is Your Biobank Ready for the Challenge of Biomarker-based Research?
|
Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems. Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
|
|
|
|
|
 |
 |
News and Press Releases |
 |
New laboratory and regulatory services for biotech customers
USA/Germany, September 21, 2020. Gerresheimer adds essential laboratory
and regulatory services to its broad portfolio of products, solutions
and services for biotech companies. Specialized laboratory technicians
and an experienced team of further specialists offer these services in
the two innovation and technology centers in Bünde (Germany) and
Vineland (New Jersey/USA). Gx Biological Solutions offers full service
for biotech companies regarding product development of primary packaging
and drug delivery solutions, material and functional testing as well as
comprehensive regulatory support. The partnership with Gerresheimer
shortens the time to market for pharmaceutical companies, minimizes
risks and saves resources.
More info >> |
|
 |
White Papers |
 |
The EC Definition of a Nanomaterial - Potential Measurement Methodologies
NanoSight
In October 2011 the European Commission
published a definition of Nanomaterials. This move followed more than six
years of scientific consideration of the potential toxicological and
environmental challenges posed by engineered nanomaterials.
More info >> |
|
 |
Industry Events |
 |
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
8-11 February 2021, Vienna, Austria
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >> |
|
|
|